• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型单克隆抗体1C5,可与人子宫颈腺癌发生反应,具有免疫诊断潜力。

New monoclonal antibody, 1C5, reactive with human cervical adenocarcinoma of the uterus, with immunodiagnostic potential.

作者信息

Koizumi M, Uede T, Shijubo N, Kudo R, Hashimoto M, Kikuchi K

机构信息

Department of Pathology, Sapporo Medical College, Japan.

出版信息

Cancer Res. 1988 Nov 15;48(22):6565-72.

PMID:3052807
Abstract

A murine monoclonal antibody, 1C5, was produced by fusion of spleen cells obtained from mice immunized with CAC-1, a human cell line of adenocarcinoma derived from uterine cervix, and NS/1 myeloma cells. 1C5 can be used for the staining of routine formalin-fixed and paraffin-embedded tissue sections. 1C5-defined antigen was found to have a molecular weight of 26,000. The 1C5-defined antigen was resistant to neuraminidase and trypsin treatment, but sensitive to periodate treatment, indicating that an epitope of the 1C5-defined antigen is a carbohydrate moiety. Immunohistochemical study using immunoperoxidase staining demonstrated that 1C5 reacted with 87% of adenocarcinomas of the uterine cervix, 39% of endometrial carcinomas of the uterus, 100% of ovarian mucinous cystadenocarcinomas, 43% of ovarian serous cystadenocarcinomas, 45% of adenocarcinomas of the colon, and 40% of gastric adenocarcinomas, thus showing the broad reactivity to adenocarcinoma cells of various origins. However, 1C5 did not show any reactivity to ectocervix epithelium, cervical intraepithelial neoplasia, or squamous cell carcinoma of the uterine cervix. In addition, adenocarcinoma of the uterine cervix exhibited strong cytoplasmic reactivity with 1C5, whereas endometrial carcinoma of the uterus showed the luminal reactivity. 1C5 also reacts with 95% ethanol-fixed malignant cells in cervical smears.

摘要

一种鼠单克隆抗体1C5,是通过将用CAC - 1(一种源自子宫颈的人腺癌细胞系)免疫的小鼠的脾细胞与NS/1骨髓瘤细胞融合产生的。1C5可用于常规福尔马林固定和石蜡包埋组织切片的染色。发现1C5所识别的抗原分子量为26,000。1C5所识别的抗原对神经氨酸酶和胰蛋白酶处理具有抗性,但对高碘酸盐处理敏感,表明1C5所识别抗原的一个表位是碳水化合物部分。使用免疫过氧化物酶染色的免疫组织化学研究表明,1C5与87%的子宫颈腺癌、39%的子宫内膜癌、100%的卵巢黏液性囊腺癌、43%的卵巢浆液性囊腺癌、45%的结肠癌和40%的胃腺癌发生反应,从而显示出对各种来源的腺癌细胞具有广泛的反应性。然而,1C5对外宫颈上皮、宫颈上皮内瘤变或子宫颈鳞状细胞癌没有任何反应性。此外,子宫颈腺癌与1C5表现出强烈的细胞质反应性,而子宫内膜癌则表现出管腔反应性。1C5也与宫颈涂片中95%乙醇固定的恶性细胞发生反应。

相似文献

1
New monoclonal antibody, 1C5, reactive with human cervical adenocarcinoma of the uterus, with immunodiagnostic potential.新型单克隆抗体1C5,可与人子宫颈腺癌发生反应,具有免疫诊断潜力。
Cancer Res. 1988 Nov 15;48(22):6565-72.
2
[The production and characterization of monoclonal antibody, 1C5, reactive with cervical adenocarcinoma of the uterus].[与子宫颈腺癌反应的单克隆抗体1C5的制备与特性鉴定]
Nihon Sanka Fujinka Gakkai Zasshi. 1989 May;41(5):530-6.
3
A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas.一种在人类子宫癌和卵巢癌中表达的新型肿瘤相关抗原。
Cancer. 1996 Apr 15;77(8):1501-9. doi: 10.1002/(SICI)1097-0142(19960415)77:8<1501::AID-CNCR12>3.0.CO;2-3.
4
[The production and reactivity of the monoclonal antibody (MCA-97) to endometrial adenocarcinoma].[抗子宫内膜腺癌单克隆抗体(MCA-97)的产生及反应性]
Nihon Sanka Fujinka Gakkai Zasshi. 1986 Jan;38(1):53-8.
5
[Development of the monoclonal antibody to cultured uterine endometrial adenocarcinoma cells (EI)].[针对培养的子宫内膜腺癌细胞(EI)的单克隆抗体的研制]
Nihon Sanka Fujinka Gakkai Zasshi. 1995 Jul;47(7):635-42.
6
Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas.单克隆抗体DF3与人类卵巢癌中表达的一种高分子量抗原的反应性。
Cancer Res. 1986 Oct;46(10):5189-94.
7
Common antigenic sites on exfoliated cells derived from cervical carcinoma and in tumor cells of nonuterine origin as demonstrated by monoclonal antibodies in immunoperoxidase assay.免疫过氧化物酶测定中,单克隆抗体所证实的宫颈癌脱落细胞及非子宫来源肿瘤细胞上的共同抗原位点。
Cancer Res. 1985 Nov;45(11 Pt 2):5964-8.
8
Immunohistochemical comparison of new monoclonal antibody 1C5 and carcinoembryonic antigen in the differential diagnosis of adenocarcinoma of the uterine cervix.
Int J Gynecol Pathol. 1990;9(4):325-36. doi: 10.1097/00004347-199010000-00004.
9
TDM35--a new monoclonal antibody to the XH1 cervical carcinoma cell line. Characterization and immunoperoxidase localization in benign and malignant tissues.TDM35——一种针对XH1宫颈癌细胞系的新型单克隆抗体。在良性和恶性组织中的特性及免疫过氧化物酶定位
J Pathol. 1992 Aug;167(4):391-7. doi: 10.1002/path.1711670408.
10
Cytoplasmic reactivity with the monoclonal antibody HMFG1 as a marker of cervical glandular atypia.使用单克隆抗体HMFG1作为宫颈腺上皮异型性标志物的细胞质反应性。
J Pathol. 1987 Mar;151(3):203-8. doi: 10.1002/path.1711510308.

引用本文的文献

1
Homeobox gene expression and mutation in cervical carcinoma cells.子宫颈癌细胞中的同源盒基因表达与突变
Cancer Sci. 2003 May;94(5):437-41. doi: 10.1111/j.1349-7006.2003.tb01461.x.
2
Semiquantitative immunohistochemical studies of blood group antigen A, B, H, Le(a), Le(b) structures and Ii backbone chains in the normal human cervix and in cervical adenocarcinoma.正常人体宫颈及宫颈腺癌中血型抗原A、B、H、Le(a)、Le(b)结构和Ii主链的半定量免疫组织化学研究
Histochem J. 1993 Mar;25(3):228-41. doi: 10.1007/BF00163819.
3
Integrin expression and ability to adhere to extracellular matrix proteins and endothelial cells in human lung cancer lines.
Br J Cancer. 1994 Sep;70(3):466-73. doi: 10.1038/bjc.1994.329.
4
Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas.将MN抗原鉴定为宫颈上皮内鳞状和腺性肿瘤以及宫颈癌的诊断生物标志物。
Am J Pathol. 1994 Sep;145(3):598-609.
5
Characterization of a human cervical carcinoma-associated antigen by lectin binding and immuno-electron microscopy.通过凝集素结合和免疫电子显微镜对一种人宫颈癌相关抗原的特性进行鉴定。
Histochemistry. 1992 Jul;97(6):453-61. doi: 10.1007/BF00316064.
6
Circulating intercellular adhesion molecule-1 (ICAM-1) antigen in sera of patients with idiopathic pulmonary fibrosis.特发性肺纤维化患者血清中循环细胞间黏附分子-1(ICAM-1)抗原
Clin Exp Immunol. 1992 Jul;89(1):58-62. doi: 10.1111/j.1365-2249.1992.tb06877.x.